<VariationArchive VariationID="265282" VariationName="NM_207346.3(TSEN54):c.670_671del (p.Lys224fs)" VariationType="Deletion" Accession="VCV000265282" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2016-10-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="260190" VariationID="265282">
      <GeneList>
        <Gene Symbol="TSEN54" FullName="tRNA splicing endonuclease subunit 54" GeneID="283989" HGNC_ID="HGNC:27561" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="75516528" stop="75524735" display_start="75516528" display_stop="75524735" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="73512608" stop="73520819" display_start="73512608" display_stop="73520819" Strand="+" />
          </Location>
          <OMIM>608755</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_207346.3(TSEN54):c.670_671del (p.Lys224fs)</Name>
      <CanonicalSPDI>NC_000017.11:75521750:AA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="75521751" stop="75521752" display_start="75521751" display_stop="75521752" variantLength="2" positionVCF="75521750" referenceAlleleVCF="CAA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="73517832" stop="73517833" display_start="73517832" display_stop="73517833" variantLength="2" positionVCF="73517831" referenceAlleleVCF="CAA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K224fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.73517832_73517833del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.73517832_73517833del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.75521751_75521752del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.75521751_75521752del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013041.1" sequenceAccession="NG_013041" sequenceVersion="1" change="g.10224_10225del">
            <Expression>NG_013041.1:g.10224_10225del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_207346.3" sequenceAccession="NM_207346" sequenceVersion="3" change="c.670_671del" MANESelect="true">
            <Expression>NM_207346.3:c.670_671del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_997229.2" sequenceAccession="NP_997229" sequenceVersion="2" change="p.Lys224fs">
            <Expression>NP_997229.2:p.Lys224fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA8764245" DB="ClinGen" />
        <XRef Type="rs" ID="762142684" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_207346.3(TSEN54):c.670_671del (p.Lys224fs) AND not provided" Accession="RCV000255134" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-30" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_207346.3(TSEN54):c.670_671del (p.Lys224fs) AND multiple conditions" Accession="RCV002487169" Version="1">
        <ClassifiedConditionList TraitSetID="22731">
          <ClassifiedCondition DB="MedGen" ID="C1848526">Pontocerebellar hypoplasia type 2A</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1856974">Pontocerebellar hypoplasia type 4</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1857762">Pontocerebellar hypoplasia type 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-30" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2016-10-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18711368</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20952379</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="22731" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3365" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pontocerebellar hypoplasia type 4</ElementValue>
                <XRef ID="Pontocerebellar+hypoplasia+type+4/5866" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009166" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Encephalopathy fatal infantile with olivopontocerebellar hypoplasia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PCH4</ElementValue>
                <XRef Type="MIM" ID="225753" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and neurologic findings. The three PCH phenotypes (which differ mainly in life expectancy) were considered to be distinct entities before their molecular basis was known. PCH2. Children usually succumb before age ten years (those with PCH4 and 5 usually succumb as neonates). Children with PCH2 have generalized clonus, uncoordinated sucking and swallowing, impaired cognitive development, lack of voluntary motor development, cortical blindness, and an increased risk for rhabdomyolysis during severe infections. Epilepsy is present in approximately 50%. PCH4. Neonates often have seizures, multiple joint contractures ("arthrogryposis"), generalized clonus, and central respiratory impairment. PCH5 resembles PCH4 and has been described in one family.</Attribute>
                <XRef ID="NBK9673" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="343" />
                <XRef ID="343" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301773</ID>
                <ID Source="BookShelf">NBK9673</ID>
              </Citation>
              <XRef ID="166063" DB="Orphanet" />
              <XRef ID="C1856974" DB="MedGen" />
              <XRef ID="MONDO:0009166" DB="MONDO" />
              <XRef Type="MIM" ID="225753" DB="OMIM" />
            </Trait>
            <Trait ID="3519" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VOLENDAM NEURODEGENERATIVE DISEASE</ElementValue>
                <XRef Type="MIM" ID="277470" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pontocerebellar hypoplasia type 2A</ElementValue>
                <XRef ID="Pontocerebellar+hypoplasia+type+2A/9133" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010190" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PONTOCEREBELLAR HYPOPLASIA WITH PROGRESSIVE CEREBRAL ATROPHY</ElementValue>
                <XRef Type="MIM" ID="277470" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PCH2A</ElementValue>
                <XRef Type="MIM" ID="277470" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and neurologic findings. The three PCH phenotypes (which differ mainly in life expectancy) were considered to be distinct entities before their molecular basis was known. PCH2. Children usually succumb before age ten years (those with PCH4 and 5 usually succumb as neonates). Children with PCH2 have generalized clonus, uncoordinated sucking and swallowing, impaired cognitive development, lack of voluntary motor development, cortical blindness, and an increased risk for rhabdomyolysis during severe infections. Epilepsy is present in approximately 50%. PCH4. Neonates often have seizures, multiple joint contractures ("arthrogryposis"), generalized clonus, and central respiratory impairment. PCH5 resembles PCH4 and has been described in one family.</Attribute>
                <XRef ID="NBK9673" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15244" />
                <XRef ID="15244" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3631" />
                <XRef ID="3631" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301773</ID>
                <ID Source="BookShelf">NBK9673</ID>
              </Citation>
              <XRef ID="2524" DB="Orphanet" />
              <XRef ID="C1848526" DB="MedGen" />
              <XRef ID="MONDO:0010190" DB="MONDO" />
              <XRef Type="MIM" ID="277470" DB="OMIM" />
            </Trait>
            <Trait ID="3520" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Olivopontocerebellar hypoplasia fetal-onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pontocerebellar hypoplasia type 5</ElementValue>
                <XRef ID="Pontocerebellar+hypoplasia+type+5/5867" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012438" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PCH5</ElementValue>
                <XRef Type="MIM" ID="610204" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and neurologic findings. The three PCH phenotypes (which differ mainly in life expectancy) were considered to be distinct entities before their molecular basis was known. PCH2. Children usually succumb before age ten years (those with PCH4 and 5 usually succumb as neonates). Children with PCH2 have generalized clonus, uncoordinated sucking and swallowing, impaired cognitive development, lack of voluntary motor development, cortical blindness, and an increased risk for rhabdomyolysis during severe infections. Epilepsy is present in approximately 50%. PCH4. Neonates often have seizures, multiple joint contractures ("arthrogryposis"), generalized clonus, and central respiratory impairment. PCH5 resembles PCH4 and has been described in one family.</Attribute>
                <XRef ID="NBK9673" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10709" />
                <XRef ID="10709" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301773</ID>
                <ID Source="BookShelf">NBK9673</ID>
              </Citation>
              <XRef ID="166068" DB="Orphanet" />
              <XRef ID="C1857762" DB="MedGen" />
              <XRef ID="MONDO:0012438" DB="MONDO" />
              <XRef Type="MIM" ID="610204" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="616636" SubmissionDate="2019-01-29" DateLastUpdated="2016-10-10" DateCreated="2016-10-10">
        <ClinVarSubmissionID localKey="GDX:64200|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000321983" DateUpdated="2016-10-10" DateCreated="2016-10-10" Type="SCV" Version="7" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.670_671delAA variant causes a frameshift starting with codon Lysine 224, changes this amino acid to a Glutamic acid residue and creates a premature Stop codon at position 69 of the new reading frame, denoted p.Lys224GlufsX69. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Although this variant has not been previously reported to our knowledge, other frameshift mutations have been reported in the TSEN54 gene (Stenson et al., 2014). Therefore, c.670_671delAA is considered a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TSEN54" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_207346.2:c.670_671delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5427867" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_207346.3:c.670_671del|OMIM:225753;277470;610204" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002775274" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_207346.3:c.670_671del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="225753" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277470" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610204" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8005328" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="2709275|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004322029" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18711368</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20952379</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys224Glufs*69) in the TSEN54 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSEN54 are known to be pathogenic (PMID: 18711368, 20952379). This variant is present in population databases (rs762142684, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with TSEN54-related conditions. ClinVar contains an entry for this variant (Variation ID: 265282). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TSEN54" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.73517832_73517833del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="616636" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8005328" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5427867" TraitType="Disease" MappingType="XRef" MappingValue="277470" MappingRef="OMIM">
        <MedGen CUI="C1848526" Name="Pontocerebellar hypoplasia type 2A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5427867" TraitType="Disease" MappingType="XRef" MappingValue="610204" MappingRef="OMIM">
        <MedGen CUI="C1857762" Name="Pontocerebellar hypoplasia type 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5427867" TraitType="Disease" MappingType="XRef" MappingValue="225753" MappingRef="OMIM">
        <MedGen CUI="C1856974" Name="Pontocerebellar hypoplasia type 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

